Kufel, W. D., Zayac, A. S., Lehmann, D. F., & Miller, C. D. (2016). Clinical Application and Pharmacodynamic Monitoring of Apixaban in a Patient with End-Stage Renal Disease Requiring Chronic Hemodialysis. Pharmacotherapy, 36(11), e166. https://doi.org/10.1002/phar.1836
Chicago Style (17th ed.) CitationKufel, Wesley D., Adam S. Zayac, David F. Lehmann, and Christopher D. Miller. "Clinical Application and Pharmacodynamic Monitoring of Apixaban in a Patient with End-Stage Renal Disease Requiring Chronic Hemodialysis." Pharmacotherapy 36, no. 11 (2016): e166. https://doi.org/10.1002/phar.1836.
MLA (9th ed.) CitationKufel, Wesley D., et al. "Clinical Application and Pharmacodynamic Monitoring of Apixaban in a Patient with End-Stage Renal Disease Requiring Chronic Hemodialysis." Pharmacotherapy, vol. 36, no. 11, 2016, p. e166, https://doi.org/10.1002/phar.1836.